Marielle Yohe

18PUBLICATIONS
173CO-AUTHORS
Molecular targetsCentral nervous systemCancer geneticsPredictive and prognostic markersCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 08, 2026
HRAS promotes mutant NRAS-driven transformation with codon and allele specificity.

|Feb 11, 2026
Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma.

Patience Odeniyide, Alyza Skaist, Elizabeth Fenner

|Jan 24, 2026
Wide Ranging Neurobehavioral Phenotype in Individuals With Costello Syndrome.

Millicent S Curlee, Atara Siegel, Paige Little

|Dec 04, 2025
Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer.

Hannah E Price, Stacey Stauffer, Hyun Lee

|Sep 16, 2025
Wild-type RAS signaling is an essential therapeutic target in RAS-mutated cancers.

Nancy E Sealover, Bridget A Finniff, Jacob M Hughes

|Nov 04, 2024
ASAP1 and ARF1 Regulate Myogenic Differentiation in Rhabdomyosarcoma by Modulating TAZ Activity.

Katie E Hebron, Olivia L Perkins, Angela Kim

Pageof 3

Frequent Collaborators

6 joint publications

Jack Shern

4 joint publications

Haiyan Lei

4 joint publications

Robert L Kortum

4 joint publications

Katie E Hebron